Aminobisphosphonate stimulates bone regeneration and enforces consolidation of titanium implant into a new rat caudal vertebrae model

József Blazsek, Csaba Dobó Nagy, István Blazsek, Rita Varga, Bálint Vecsei, P. Fejérdy, G. Varga

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Bisphosphonates are widely used as therapeutic agents in bone disorders including cancer metastasis due to their osteoclast inhibitory effect. Recent data shows that bisphosphonates may also induce bone-building by stimulating osteoblast activity. Clinical observations, however, have revealed that bisphosphonates may cause necrosis in the oral cavity which questions their usefulness in bone regeneration during the consolidation of inorganic implants. Here we report the investigation of bone neogenesis following chronic amine bisphosphonate (Zometa®) treatment in a novel experimental model, using the rat tail vertebra as a support. This method involves (1) implantation of titan screw into the tail vertebrae, (2) systemic bisphosphonate treatment and (3) quantitative biophysical measurements which mirrors consolidation of implant, i.e. strength of fixation and changes in newly formed bone architecture using micro Computer Tomograph (micro-CT). The degree of fixation of titan implants (osseointegration) increased by 36% on the effect of Zometa and the structure of newly formed bone became robust. The mass of new bone increased 3.1-fold at 6 weeks of regeneration, as compared to controls. Thus, Zometa®, a potent aminobisphosphonate used in therapy of cancer metastases, osteoporosis and bone marrow transplantation, significantly increased bone neogenesis and enforced osseointegration of titan implants as measured quantitatively in the rat tail vertebra. Our data support the usefulness of aminobisphosphonates in the rehabilitation of bone loss as well as in improvement osseointegration of implants. We emphasise that this novel method may open up new possibilities for screening the effects of local and systemic treatments.

Original languageEnglish
Pages (from-to)567-577
Number of pages11
JournalPathology and Oncology Research
Volume15
Issue number4
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Bone Regeneration
Titanium
zoledronic acid
Spine
Diphosphonates
Bone and Bones
Saturn
Osseointegration
Tail
Neoplasm Metastasis
Therapeutics
Osteoclasts
Osteoblasts
Bone Marrow Transplantation
Osteoporosis
Amines
Mouth
Regeneration
Neoplasms
Theoretical Models

Keywords

  • Aminobisphosphonates (Zometa®)
  • Biomechanical measurement
  • Bone regeneration
  • Micro computer tomography (micro-CT)
  • New implant osseointegration model
  • Osteo-neogenesis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pathology and Forensic Medicine

Cite this

Aminobisphosphonate stimulates bone regeneration and enforces consolidation of titanium implant into a new rat caudal vertebrae model. / Blazsek, József; Dobó Nagy, Csaba; Blazsek, István; Varga, Rita; Vecsei, Bálint; Fejérdy, P.; Varga, G.

In: Pathology and Oncology Research, Vol. 15, No. 4, 12.2009, p. 567-577.

Research output: Contribution to journalArticle

Blazsek, József ; Dobó Nagy, Csaba ; Blazsek, István ; Varga, Rita ; Vecsei, Bálint ; Fejérdy, P. ; Varga, G. / Aminobisphosphonate stimulates bone regeneration and enforces consolidation of titanium implant into a new rat caudal vertebrae model. In: Pathology and Oncology Research. 2009 ; Vol. 15, No. 4. pp. 567-577.
@article{1b588ef67a8c4cd49841ac686b587ed5,
title = "Aminobisphosphonate stimulates bone regeneration and enforces consolidation of titanium implant into a new rat caudal vertebrae model",
abstract = "Bisphosphonates are widely used as therapeutic agents in bone disorders including cancer metastasis due to their osteoclast inhibitory effect. Recent data shows that bisphosphonates may also induce bone-building by stimulating osteoblast activity. Clinical observations, however, have revealed that bisphosphonates may cause necrosis in the oral cavity which questions their usefulness in bone regeneration during the consolidation of inorganic implants. Here we report the investigation of bone neogenesis following chronic amine bisphosphonate (Zometa{\circledR}) treatment in a novel experimental model, using the rat tail vertebra as a support. This method involves (1) implantation of titan screw into the tail vertebrae, (2) systemic bisphosphonate treatment and (3) quantitative biophysical measurements which mirrors consolidation of implant, i.e. strength of fixation and changes in newly formed bone architecture using micro Computer Tomograph (micro-CT). The degree of fixation of titan implants (osseointegration) increased by 36{\%} on the effect of Zometa and the structure of newly formed bone became robust. The mass of new bone increased 3.1-fold at 6 weeks of regeneration, as compared to controls. Thus, Zometa{\circledR}, a potent aminobisphosphonate used in therapy of cancer metastases, osteoporosis and bone marrow transplantation, significantly increased bone neogenesis and enforced osseointegration of titan implants as measured quantitatively in the rat tail vertebra. Our data support the usefulness of aminobisphosphonates in the rehabilitation of bone loss as well as in improvement osseointegration of implants. We emphasise that this novel method may open up new possibilities for screening the effects of local and systemic treatments.",
keywords = "Aminobisphosphonates (Zometa{\circledR}), Biomechanical measurement, Bone regeneration, Micro computer tomography (micro-CT), New implant osseointegration model, Osteo-neogenesis",
author = "J{\'o}zsef Blazsek and {Dob{\'o} Nagy}, Csaba and Istv{\'a}n Blazsek and Rita Varga and B{\'a}lint Vecsei and P. Fej{\'e}rdy and G. Varga",
year = "2009",
month = "12",
doi = "10.1007/s12253-009-9156-y",
language = "English",
volume = "15",
pages = "567--577",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Aminobisphosphonate stimulates bone regeneration and enforces consolidation of titanium implant into a new rat caudal vertebrae model

AU - Blazsek, József

AU - Dobó Nagy, Csaba

AU - Blazsek, István

AU - Varga, Rita

AU - Vecsei, Bálint

AU - Fejérdy, P.

AU - Varga, G.

PY - 2009/12

Y1 - 2009/12

N2 - Bisphosphonates are widely used as therapeutic agents in bone disorders including cancer metastasis due to their osteoclast inhibitory effect. Recent data shows that bisphosphonates may also induce bone-building by stimulating osteoblast activity. Clinical observations, however, have revealed that bisphosphonates may cause necrosis in the oral cavity which questions their usefulness in bone regeneration during the consolidation of inorganic implants. Here we report the investigation of bone neogenesis following chronic amine bisphosphonate (Zometa®) treatment in a novel experimental model, using the rat tail vertebra as a support. This method involves (1) implantation of titan screw into the tail vertebrae, (2) systemic bisphosphonate treatment and (3) quantitative biophysical measurements which mirrors consolidation of implant, i.e. strength of fixation and changes in newly formed bone architecture using micro Computer Tomograph (micro-CT). The degree of fixation of titan implants (osseointegration) increased by 36% on the effect of Zometa and the structure of newly formed bone became robust. The mass of new bone increased 3.1-fold at 6 weeks of regeneration, as compared to controls. Thus, Zometa®, a potent aminobisphosphonate used in therapy of cancer metastases, osteoporosis and bone marrow transplantation, significantly increased bone neogenesis and enforced osseointegration of titan implants as measured quantitatively in the rat tail vertebra. Our data support the usefulness of aminobisphosphonates in the rehabilitation of bone loss as well as in improvement osseointegration of implants. We emphasise that this novel method may open up new possibilities for screening the effects of local and systemic treatments.

AB - Bisphosphonates are widely used as therapeutic agents in bone disorders including cancer metastasis due to their osteoclast inhibitory effect. Recent data shows that bisphosphonates may also induce bone-building by stimulating osteoblast activity. Clinical observations, however, have revealed that bisphosphonates may cause necrosis in the oral cavity which questions their usefulness in bone regeneration during the consolidation of inorganic implants. Here we report the investigation of bone neogenesis following chronic amine bisphosphonate (Zometa®) treatment in a novel experimental model, using the rat tail vertebra as a support. This method involves (1) implantation of titan screw into the tail vertebrae, (2) systemic bisphosphonate treatment and (3) quantitative biophysical measurements which mirrors consolidation of implant, i.e. strength of fixation and changes in newly formed bone architecture using micro Computer Tomograph (micro-CT). The degree of fixation of titan implants (osseointegration) increased by 36% on the effect of Zometa and the structure of newly formed bone became robust. The mass of new bone increased 3.1-fold at 6 weeks of regeneration, as compared to controls. Thus, Zometa®, a potent aminobisphosphonate used in therapy of cancer metastases, osteoporosis and bone marrow transplantation, significantly increased bone neogenesis and enforced osseointegration of titan implants as measured quantitatively in the rat tail vertebra. Our data support the usefulness of aminobisphosphonates in the rehabilitation of bone loss as well as in improvement osseointegration of implants. We emphasise that this novel method may open up new possibilities for screening the effects of local and systemic treatments.

KW - Aminobisphosphonates (Zometa®)

KW - Biomechanical measurement

KW - Bone regeneration

KW - Micro computer tomography (micro-CT)

KW - New implant osseointegration model

KW - Osteo-neogenesis

UR - http://www.scopus.com/inward/record.url?scp=75049084669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75049084669&partnerID=8YFLogxK

U2 - 10.1007/s12253-009-9156-y

DO - 10.1007/s12253-009-9156-y

M3 - Article

C2 - 19267222

AN - SCOPUS:75049084669

VL - 15

SP - 567

EP - 577

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

IS - 4

ER -